Your browser doesn't support javascript.
loading
Modulation of the tumor microenvironment with an oncolytic adenovirus for effective T-cell therapy and checkpoint inhibition.
Santos, João Manuel; Havunen, Riikka; Hemminki, Akseli.
Affiliation
  • Santos JM; Cancer Gene Therapy Group, Translational Immunology Research Program and Department of Oncology, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland.
  • Havunen R; Cancer Gene Therapy Group, Translational Immunology Research Program and Department of Oncology, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland.
  • Hemminki A; Cancer Gene Therapy Group, Translational Immunology Research Program and Department of Oncology, University of Helsinki, Helsinki, Finland; TILT Biotherapeutics Ltd, Helsinki, Finland; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland. Electronic address: akseli.hemminki@helsinki.fi.
Methods Enzymol ; 635: 205-230, 2020.
Article in En | MEDLINE | ID: mdl-32122546
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Microenvironment / Neoplasms Limits: Humans Language: En Journal: Methods Enzymol Year: 2020 Document type: Article Affiliation country: Finland Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Microenvironment / Neoplasms Limits: Humans Language: En Journal: Methods Enzymol Year: 2020 Document type: Article Affiliation country: Finland Country of publication: United States